Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

By LabMedica International staff writers
Posted on 09 Feb 2024

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers (CE sequencers). More...

This collaboration stems from the outcomes of joint research conducted since the signing of a feasibility study (FS) agreement in August 2023, which focused on creating new genetic testing systems. The goal of Sysmex and Hitachi High-Tech is to produce genetic testing systems that are more efficient and cost-effective, thereby facilitating the widespread clinical application of personalized genetic testing for various diseases.

The field of genetic testing has seen significant advancements in assay reagent development using next-generation sequencing (NGS). However, there are challenges such as reducing measurement times and operational costs, underscoring the need for novel genetic testing systems suitable for widespread clinical use. To address these challenges, the companies signed the FS agreement in August 2023. The agreement aimed at exploring the development of new genetic testing systems that could offer optimal genetic analysis for individual diseases. This would be achieved by combining Hitachi High-Tech’s CE sequencer technology with Sysmex’s expertise in NGS reagent development and analysis technology, both honed through the advancement of genomic medicine in clinical settings.

Having met the objectives outlined in the FS agreement, Sysmex and Hitachi High-Tech have now agreed to proceed with the development of genetic testing systems intended for broad clinical use. Hitachi High-Tech will focus on obtaining medical device approvals for their CE sequencers, while Sysmex will develop and seek regulatory approvals for testing reagents compatible with these devices, as well as developing analysis software. Initially, the collaboration will concentrate on applications in oncology before gradually extending to other disease areas. By leveraging each company’s unique technologies and expertise, Sysmex and Hitachi High-Tech aim to promote the adoption of new genetic testing systems that offer shorter measurement durations and reduced operational costs.

Related Links:
Sysmex Corporation
Hitachi High-Tech Corporation


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
New
Pipette
Accumax Smart Series
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.